HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
updated assignment column |
No edit summary |
||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 293: | Line 293: | ||
|7/1/24 | |7/1/24 | ||
| | | | ||
| | |Pending | ||
| | | | ||
|Jennelle Hodge (JH)/ Malini Sathanoori (MS) | |Jennelle Hodge (JH)/ Malini Sathanoori (MS) | ||
| Line 338: | Line 338: | ||
|[[HAEM5:Acute myeloid leukaemia with DEK::NUP214 fusion|Acute myeloid leukaemia with DEK::NUP214 fusion]] | |[[HAEM5:Acute myeloid leukaemia with DEK::NUP214 fusion|Acute myeloid leukaemia with DEK::NUP214 fusion]] | ||
|Disease | |Disease | ||
| | |Jennelle C. Hodge, PhD | ||
| | | | ||
| | | | ||
|Pending | |||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 370: | Line 370: | ||
|[[HAEM5:Acute myeloid leukaemia with RBM15::MRTFA fusion|Acute myeloid leukaemia with RBM15::MRTFA fusion]] | |[[HAEM5:Acute myeloid leukaemia with RBM15::MRTFA fusion|Acute myeloid leukaemia with RBM15::MRTFA fusion]] | ||
|Disease | |Disease | ||
| | |Jennelle C. Hodge, PhD | ||
| | | | ||
| | | | ||
|Complete | |||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 386: | Line 386: | ||
|[[HAEM5:Acute myeloid leukaemia with BCR::ABL1 fusion|Acute myeloid leukaemia with BCR::ABL1 fusion]] | |[[HAEM5:Acute myeloid leukaemia with BCR::ABL1 fusion|Acute myeloid leukaemia with BCR::ABL1 fusion]] | ||
|Disease | |Disease | ||
|Xinxiu Xu (trainee) | |(Xinxiu Xu)(trainee) Malini Sathanoori, Ph.D. | ||
| | |4/15/25 | ||
| | | | ||
| | | | ||
| Line 406: | Line 406: | ||
|7/1/24 | |7/1/24 | ||
| | | | ||
| | |Pending | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 419: | Line 419: | ||
|[[HAEM5:Acute myeloid leukaemia with MECOM rearrangement|Acute myeloid leukaemia with MECOM rearrangement]] | |[[HAEM5:Acute myeloid leukaemia with MECOM rearrangement|Acute myeloid leukaemia with MECOM rearrangement]] | ||
|Disease | |Disease | ||
| | |Gordana Raca MD PhD, | ||
|9/8/25 | |||
| | |||
| | | | ||
|Pending | |||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 438: | Line 438: | ||
|12/20/23 | |12/20/23 | ||
| | | | ||
| | |Pending | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 458: | Line 458: | ||
|JH_MS | |JH_MS | ||
| | | | ||
|Open to new author | |emailed request on 7/16/24. No response as of 9/7/25. | ||
Prior author: Xinjie Xu, PhD, FACMG | |||
Open to new author | |||
|Acute Myeloid Leukemia (AML) with Mutated NPM1 | |Acute Myeloid Leukemia (AML) with Mutated NPM1 | ||
|Xinjie Xu, PhD, FACMG | |Xinjie Xu, PhD, FACMG | ||
| Line 467: | Line 470: | ||
|[[HAEM5:Acute myeloid leukaemia with CEBPA mutation|Acute myeloid leukaemia with CEBPA mutation]] | |[[HAEM5:Acute myeloid leukaemia with CEBPA mutation|Acute myeloid leukaemia with CEBPA mutation]] | ||
|Disease | |Disease | ||
|Xinxiu Xu (trainee) | |(Xinxiu Xu)(trainee) Malini Sathanoori, Ph.D. | ||
| | |4/15/25 | ||
| | | | ||
| | | | ||
| Line 483: | Line 486: | ||
|[[HAEM5:Acute myeloid leukaemia, myelodysplasia-related|Acute myeloid leukaemia, myelodysplasia-related]] | |[[HAEM5:Acute myeloid leukaemia, myelodysplasia-related|Acute myeloid leukaemia, myelodysplasia-related]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 490: | Line 493: | ||
|JH_MS | |JH_MS | ||
| | | | ||
| | |emailed request on 5/1/24 and reminder on 10/28/24. No response as of 9/7/25 | ||
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes | |Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes | ||
|Fei Yang, MD, FACMG <br> Oregon Health & Science University | |Fei Yang, MD, FACMG <br> Oregon Health & Science University | ||
| Line 522: | Line 525: | ||
|JH_MS | |JH_MS | ||
| | | | ||
| | |Prior author: Celeste Eno, PhD | ||
Open to new author | |||
|Acute Myeloid Leukemia (AML) with Minimal Differentiation | |Acute Myeloid Leukemia (AML) with Minimal Differentiation | ||
|Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine | |Celeste Eno, PhD, Cedars Sinai Medical Center, Los Angeles, Fabiola Quintero-Rivera, MD, FACMG, University of California Irvine | ||
| Line 547: | Line 552: | ||
|[[HAEM5:Acute myeloid leukaemia without maturation|Acute myeloid leukaemia without maturation]] | |[[HAEM5:Acute myeloid leukaemia without maturation|Acute myeloid leukaemia without maturation]] | ||
|Disease | |Disease | ||
| | |Jennelle C. Hodge, PhD | ||
| | | | ||
| | | | ||
|Pending | |||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 563: | Line 568: | ||
|[[HAEM5:Acute myeloid leukaemia with maturation|Acute myeloid leukaemia with maturation]] | |[[HAEM5:Acute myeloid leukaemia with maturation|Acute myeloid leukaemia with maturation]] | ||
|Disease | |Disease | ||
| | |Jennelle C. Hodge, PhD | ||
| | | | ||
| | | | ||
|Pending | |||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 582: | Line 587: | ||
|5/1/24 | |5/1/24 | ||
| | | | ||
| | |Pending | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 595: | Line 600: | ||
|[[HAEM5:Acute myelomonocytic leukaemia|Acute myelomonocytic leukaemia]] | |[[HAEM5:Acute myelomonocytic leukaemia|Acute myelomonocytic leukaemia]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 602: | Line 607: | ||
|JH_MS | |JH_MS | ||
| | | | ||
| | |emailed request on 5/1/24 and reminder on 10/28/24. No response as of 9/7/25 | ||
|Acute Myelomonocytic Leukemia | |Acute Myelomonocytic Leukemia | ||
|Fei Yang, MD, FACMG <br> Oregon Health & Science University | |Fei Yang, MD, FACMG <br> Oregon Health & Science University | ||
| Line 611: | Line 616: | ||
|[[HAEM5:Acute monocytic leukaemia|Acute monocytic leukaemia]] | |[[HAEM5:Acute monocytic leukaemia|Acute monocytic leukaemia]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 618: | Line 623: | ||
|JH_MS | |JH_MS | ||
| | | | ||
| | |emailed request on 5/1/24 and reminder on 10/28/24. No response as of 9/7/25 | ||
|Acute Monoblastic and Monocytic Leukemia | |Acute Monoblastic and Monocytic Leukemia | ||
|Fei Yang, MD, FACMG <br> Oregon Health & Science University | |Fei Yang, MD, FACMG <br> Oregon Health & Science University | ||
| Line 630: | Line 635: | ||
|5/1/24 | |5/1/24 | ||
| | | | ||
| | |Pending | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 643: | Line 648: | ||
|[[HAEM5:Acute megakaryoblastic leukaemia|Acute megakaryoblastic leukaemia]] | |[[HAEM5:Acute megakaryoblastic leukaemia|Acute megakaryoblastic leukaemia]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 650: | Line 655: | ||
|JH_MS | |JH_MS | ||
| | | | ||
| | |emailed request on 5/1/24 and reminder on 10/28/24. No response as of 9/7/25 | ||
|Acute Megakaryoblastic Leukemia (AMKL) | |Acute Megakaryoblastic Leukemia (AMKL) | ||
|Fei Yang, MD, FACMG <br> Oregon Health & Science University | |Fei Yang, MD, FACMG <br> Oregon Health & Science University | ||
| Line 662: | Line 667: | ||
|6/11/24 | |6/11/24 | ||
| | | | ||
| | |Pending | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 698: | Line 703: | ||
|7/1/24 | |7/1/24 | ||
| | | | ||
| | |Pending | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 727: | Line 732: | ||
|[[HAEM5:Myeloid neoplasms associated with germline predisposition|Myeloid neoplasms associated with germline predisposition]] | |[[HAEM5:Myeloid neoplasms associated with germline predisposition|Myeloid neoplasms associated with germline predisposition]] | ||
|Disease | |Disease | ||
| | |Malini Sathanoori, Ph.D. | ||
|12/6/24 | |||
| | |||
| | | | ||
|Pending | |||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 743: | Line 748: | ||
|[[HAEM5:Myeloid proliferations associated with Down syndrome|Myeloid proliferations associated with Down syndrome]] | |[[HAEM5:Myeloid proliferations associated with Down syndrome|Myeloid proliferations associated with Down syndrome]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 750: | Line 755: | ||
|JH_MS | |JH_MS | ||
| | | | ||
| | |Prior author: | ||
Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO | |||
|MERGE 3 PAGES --> Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Myeloid Leukemia Associated with Down Syndrome | |MERGE 3 PAGES --> Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome + Myeloid Leukemia Associated with Down Syndrome | ||
|Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO | |Linda D Cooley, MD, MBA, Children's Mercy Hospital, Kansas City, MO | ||
| Line 942: | Line 948: | ||
|7/1/24 | |7/1/24 | ||
| | | | ||
| | |Pending | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 962: | Line 968: | ||
|JH_MS | |JH_MS | ||
| | | | ||
| | |emailed 5/1/24 | ||
|Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified | |Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified | ||
|Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine | |Narsis Attar, MD, PhD, Fabiola Quintero-Rivera, MD University of California, Irvine | ||
| Line 974: | Line 980: | ||
|5/9/24 | |5/9/24 | ||
| | | | ||
| | |Pending | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 1,007: | Line 1,013: | ||
|7/1/24 | |7/1/24 | ||
| | | | ||
| | |Pending | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 1,644: | Line 1,650: | ||
|- | |- | ||
|[[HAEM5:Monoclonal B-cell lymphocytosis|Monoclonal B-cell lymphocytosis]]||Disease||PENDING; Shashirekha Shetty | |[[HAEM5:Monoclonal B-cell lymphocytosis|Monoclonal B-cell lymphocytosis]]||Disease||PENDING; Shashirekha Shetty | ||
| || || || ||Shivani Golem (SG) | | ||9/4/2025 sent E-mail reminder|| || ||Shivani Golem (SG) | ||
| || | | || | ||
|Monoclonal B-cell Lymphocytosis | |Monoclonal B-cell Lymphocytosis | ||
| Line 1,708: | Line 1,714: | ||
| | | | ||
| | | | ||
|Sent e-mail to prev authors | |Sent e-mail to prev authors no reply | ||
| | | | ||
| | | | ||
| Line 1,724: | Line 1,730: | ||
| | | | ||
| | | | ||
|Sent e-mail to prev authors | |Sent e-mail to prev authors no reply | ||
| | | | ||
| | | | ||
| Line 1,836: | Line 1,842: | ||
|[[HAEM5:Paediatric-type follicular lymphoma|Paediatric-type follicular lymphoma]] | |[[HAEM5:Paediatric-type follicular lymphoma|Paediatric-type follicular lymphoma]] | ||
|Disease | |Disease | ||
| | |Rachel D. Burnside, PhD, MBA, FACMGG | ||
| | | | ||
|9/4/2025 sent email reminder; Last E-mail to Dr. Burnside 7/17/2024 | |9/4/2025 sent email reminder; Last E-mail to Dr. Burnside 7/17/2024 | ||
| Line 1,868: | Line 1,874: | ||
|[[HAEM5:Primary cutaneous follicle centre lymphoma|Primary cutaneous follicle centre lymphoma]] | |[[HAEM5:Primary cutaneous follicle centre lymphoma|Primary cutaneous follicle centre lymphoma]] | ||
|Disease | |Disease | ||
| | |Linlin Gao | ||
| | | | ||
|9/4/2025 Sent E-mail to remind | |||
| | | | ||
| | | | ||
| Line 1,884: | Line 1,890: | ||
|[[HAEM5:In situ mantle cell neoplasm|In situ mantle cell neoplasm]] | |[[HAEM5:In situ mantle cell neoplasm|In situ mantle cell neoplasm]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| Line 1,902: | Line 1,908: | ||
|PENDING | |PENDING | ||
| | | | ||
| | |9/4/2025 set E-mail reminder | ||
| | | | ||
| | | | ||
| Line 2,273: | Line 2,279: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|[[HAEM5:Immunoglobulin-related (AL) amyloidosis|Immunoglobulin-related (AL) amyloidosis]]||Disease|| | |[[HAEM5:Immunoglobulin-related (AL) amyloidosis|Immunoglobulin-related (AL) amyloidosis]]||Disease|| | ||
| || || || ||SG | | || || || ||SG | ||
| || | | || | ||
| Line 2,282: | Line 2,288: | ||
| | | | ||
|- | |- | ||
|[[HAEM5:Monoclonal immunoglobulin deposition disease|Monoclonal immunoglobulin deposition disease]]||Disease|| | |[[HAEM5:Monoclonal immunoglobulin deposition disease|Monoclonal immunoglobulin deposition disease]]||Disease|| | ||
| || || || ||SG | | || || || ||SG | ||
| || | | || | ||
| Line 2,299: | Line 2,305: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|[[HAEM5:Gamma heavy chain disease|Gamma heavy chain disease]]||Disease|| | |[[HAEM5:Gamma heavy chain disease|Gamma heavy chain disease]]||Disease|| | ||
| || || || ||SG | | || || || ||SG | ||
| || | | || | ||
| Line 2,316: | Line 2,322: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|[[HAEM5:Plasmacytoma|Plasmacytoma]]||Disease|| | |[[HAEM5:Plasmacytoma|Plasmacytoma]]||Disease|| | ||
| || || || | | || || || | ||
|SG | |SG | ||
| Line 2,354: | Line 2,360: | ||
|- | |- | ||
|[[HAEM5:Plasma cell neoplasms with associated paraneoplastic syndrome|Plasma cell neoplasms with associated paraneoplastic syndrome]]||Disease||PENDING | |[[HAEM5:Plasma cell neoplasms with associated paraneoplastic syndrome|Plasma cell neoplasms with associated paraneoplastic syndrome]]||Disease||PENDING | ||
| || | | ||9/4/2025 E-mail sent to Dr. Senaratne | ||
| || | |||
|SG | |SG | ||
| ||Note: author needs to include POEMS, TEMPI, and look for AESOP content | | ||Note: author needs to include POEMS, TEMPI, and look for AESOP content | ||